• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Scientific Media

  • GDE – “Scientific Media @Leaders in Pharmaceutical Business Intelligence (LPBI)”

  • http://pharmaceuticalintelligence.com/

HQS – Boston, MA

OUR CURRENT PLAN FOR FUNDING

GDE’s Scientific Media Business

We need a TOP Scientific e-Publisher to acquire

– the Journal and

– the BioMed Series

Alternatively, we need a FOUNDATION that Specializes in Funding Scientific Media or Communications to fund the Journal and the BioMed e-Series allowing to MARKET the e-Books to Cardiologists, Oncologist, in the U.S. and in Europe, explore the Market for Medical Books in Japan and China.

A.  Open Access online Scientific Journal  COVERS

We are seeking a Scientific Publisher to Publish the Journal in China and other countries in South East Asia

B.  BioMed e-Series

We are seeking a Scientific Publisher to Market our Amazon.com Medicine e-Books and Books to Cardiologists and Oncologists in CHINA

C.  Biotech and Medicine REAL TIME Press Coverage using Social Media and Tweet Analytics

We are seeking to scale up this Business to cover Conferences in Biotech and Medicine in South East Asia. We developed a methodology for REAL TIME conference coverage by Domain Experts

NEWS

10/22/2015 – 

#1: STARTEGY for the Journal

To follow up on ALL the FOUR NEEDS — we need a DEDICATED BD IN SHANGHAI

#1 – NEED for Introduction to George Institute for Global Health, China

#2  – NEED for Introduction to GEORGE CLINICAL, Australia, See e-mail, Anne Sim

LPBI the site and journal would fit perfectly. I suggest a personal agreement with them for regular interviews and postings on our site according to each individual expertise. This can and should be one on one with resultant site and tweet analytics as deliverables. Then indivual companies can work with GDE or M3DP

#3 – NEED for Introduction to Investment Funds in Healthcare in Shanghai

#4 – Medical 3D BioPrinting (M3DP) – A System Integration Start Up [3D Printer Sales, R&D Biologics, BioMed&Medical Devices]

NEED for Introduction to Private Equity INVESTOR(S) for Funding, Developing and Managing

@@@@@@@@@@@

#2: BASKET for GDE’s IT Issues

http://pharmaceuticalintelligence.com/2015/10/17/basket-for-gdes-it-issues/

@@@@@@@@@@@

  • Scientific Journal

http://pharmaceuticalintelligence.com/

On 9/23/2015

740,940 Readers

3,294 Scientific Articles

385 Categories of Research

7,106 Tags

NEWS

  • BioMed e-Series

10/22/2015

Our Director of Business Development for the Benelux and Scandinavian Counties, based in Amsterdam, Mr. Silvester Werring, has contacted on behalf of LPBI, the President of Elsevier.

Updates will follow.

Continue reading,

This e-mail is an example for

1. CONTINUOUS IMPROVEMENT procedures taking place at our BioMed e-Series

2. Collaborations among Editors Cross e-Series

3. Interaction among Editors and Editor-in-Chief

4. Parallel activities on “Marketing and Business Development” and “Editorial Development” for:

4.1 Series B: Volume one in Draft on Amazon ready for Upload, Volume Two in preliminary preparations

4.2 Series D – Decisions needed on Development, Beyond Volume 1 published in 2015 on Amazon.

4.2 Series A is Under Defined Plan – on going:

Dr. Pearlman will show progress on a Quarterly basis for FOUR Hard Copies in 2016.

4.3 Series C – Decisions PENDING on work beyond Volumes 1, published in 2015 on Amazon, and Volume 2, NOW in QA,

regarding Future of Volume 3, 4

4.4 Series E – Volume 1, Needs Editor and Development of eTOCs,

Two volumes have been completed by Dr. Larry.

Volume 4 on Medical 3D BioPrinting, Work-in-Progress

All Titles launched by Aviva.

http://pharmaceuticalintelligence.com/biomed-e-books/

Series E: Patient-Centered Medicine — e-Books Title Plan for 2015-2016

onepage series BCDE covers

This page has the following sub pages.

  • Work-in-Progress Volume One: The Patient’s Voice: Personal Experience with Invasive Medical Procedures
  • 90% DONE Volume Two: Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders
  • READY for AMAZON Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics
  • NEW TITLE Volume Four: Medical 3D BioPrinting – The Revolution in Medicine

Series C: Cancer Volume Two — Deadline PENDING for Dr. Sag and Dr. Raphael Nir

NEWS

  • Biotech and Medicine Conferences — REAL TIME Press Coverage using Social Media and Tweet Analytics

http://pharmaceuticalintelligence.com/2015/08/15/press-release-on-amazon-com-biomedical-e-books-e-series-by-the-team-of-leaders-in-pharmaceutical-business-intelligence-cardiovascular-genomics-cancer-biomed-patient-centered-medicine/

Forthcoming

The 11th Annual Personalized Medicine Conference, November 18-19, 2015, Joseph B. Martin Conference Center of the Harvard New Research Building at Harvard Medical School

http://pharmaceuticalintelligence.com/2015/07/09/the-11th-annual-personalized-medicine-conference-november-18-19-2015-joseph-b-martin-conference-center-of-the-harvard-new-research-building-at-harvard-medical-school/

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,056 other subscribers
  • Recent Posts

    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
    • 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage January 6, 2026
    • Workflow for Dynamic Linkage and Transition between two Authoring Systems: LPBI Group’s WordPress.com Multi-Authors Authoring System and Microsoft PowerPoint product for Slide show presentation – Part 10.1 in Composition of Methods January 6, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


 

Loading Comments...
 

    %d